A Modified Method for Reducing Renal Injury in Zoledronic Acid Treatment of Hypercalcemia and Adverse Skeletal Events

AIMS: In this paper, we have reported a previously undescribed risk factor of deterioration of renal function in zoledronic acid treatment of skeletal metastasis – high serum calcium level. Based on this consideration, a modified method of treatment of hypercalcemia (HCM) with zoledronic acid is sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiang, Zheng, Liqun, Zhang, Wenhua, Chang, Keli, Pang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680841/
https://www.ncbi.nlm.nih.gov/pubmed/23766597
http://dx.doi.org/10.4103/0973-1075.110239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680841/
https://www.ncbi.nlm.nih.gov/pubmed/23766597
http://dx.doi.org/10.4103/0973-1075.110239

Ejemplares similares